Co-founding CEO, Gene Therapy

Job not on LinkedIn

November 4

Apply Now

Receive Emails with Similar Jobs

New Leaders Council

WebsiteLinkedInAll Job Openings

Education • Non-profit • Social Impact

New Leaders Council is a 501(c)(3) organization dedicated to transforming leadership in the United States by providing innovative training and support to a new generation of leaders. Focusing on equity and inclusion, NLC empowers local changemakers, particularly those from historically marginalized communities, by offering a place-based learning experience through the NLC Institute. The organization fosters collaboration and builds a national network of alumni who are equipped to drive cultural and electoral progress, addressing the nation’s most pressing challenges with bold and visionary leadership.

2 - 10 employees

Founded 2005

📚 Education

🤝 Non-profit

🌍 Social Impact

📋 Description

• Lead the company’s overall strategy, growth, and fundraising, securing seed and Series A investment • Drive the scientific and clinical roadmap in collaboration with the CSO toward IND readiness for the CMT2D program while expanding the broader tRNA platform • Build and inspire a multidisciplinary team that combines scientific excellence with entrepreneurial focus • Establish strong partnerships with investors, academic collaborators, pharmaceutical partners, and patient foundations • Represent XtRNA Bio externally, communicating our vision, progress, and potential to the biotech and investment communities

🎯 Requirements

• Advanced degree (PhD or MD) in Life Sciences, Biotechnology, Genetics, or a related field; business training (MBA or equivalent) is an advantage • Proven experience in leading or scaling biotech or pharmaceutical ventures (ideally within RNA therapeutics, gene therapy, or rare disease) • Demonstrated success in fundraising, including venture capital and strategic partnerships • Proven track record in strategic transactions, including co-development partnerships, M&A, or successful exits with biotech or pharmaceutical companies • Track record of translating early-stage scientific innovation into clinical development and tangible company value • Strong scientific understanding of delivery technologies such as AAV capsids or related gene therapies and RNA biology and genetic disease mechanisms • Familiarity with regulatory pathways, translational medicine, and early clinical development for rare diseases • Entrepreneurial, hands-on, and comfortable operating in a dynamic, high-growth environment

🏖️ Benefits

• Primarily equity-based compensation • Modest base salary until fundraising